Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dina

Dina Alrashawi, Huntington Beach, CA US

Patent application numberDescriptionPublished
20100323941Automatic Dishwashing Detergent - An automatic dishwashing detergent, comprising, by weight: 2-10% sodium citrate dehydrate; 0.5 to 2.0% citric acid; 0.5 to 10.0% of a first surfactant, 0.8 to 1.1% xanthan gum; 0.1 to 5.0% of an enzyme; 0.5 to 10.0% of a second surfactant; and the balance being water. The dishwashing detergent can optionally include a preservative and/or an essential oil.12-23-2010

Dina Bruzek, Dayton, MD US

Patent application numberDescriptionPublished
20100205675SYSTEMS AND METHODS FOR MODIFYING NETWORK MAP ATTRIBUTES - The disclosed systems and methods provide a user interface for modifying host configuration data that has been automatically and passively determined and for adding or modifying other parameters associated with a host. A host data table can store various parameters descriptive of a host including the applicability of specific vulnerabilities. If it is determined that one or more hosts should not be identified as associated with a specific vulnerability, a graphical user interface can be used to modify the vulnerability parameter.08-12-2010

Dina Burakov, Edison, NJ US

Patent application numberDescriptionPublished
20080299154COSMETIC HAIR COMPOSITIONS CONTAINING METAL-OXIDE LAYERED PIGMENTS AND METHODS OF USE - The disclosure relates to cosmetic hair compositions containing metal-oxide layered pigments. The disclosure also relates to the use of the metal-oxide layered pigments in cosmetic hair compositions. The disclosure also relates to compositions containing film-formers and stabilizers in combination with the metal-oxide layered pigments.12-04-2008

Patent applications by Dina Burakov, Edison, NJ US

Dina Fischer, Rehovot IL

Patent application numberDescriptionPublished
20080219952Process For the Preparation of Glycosylated Interferon Beta - The present invention relates to a process for the production of interferon beta, and to an interferon beta composition having a unique glycosylation pattern.09-11-2008
20110305669PROCESS FOR THE PREPARATION OF GLYCOSYLATED INTERFERON BETA - The present invention relates to a process for the production of interferon beta, and to an interferon beta composition having a unique glycosylation pattern.12-15-2011

Dina Grudo, Allen, TX US

Patent application numberDescriptionPublished
20120095293COMBINED IRRIGATION AND RINSING TUBE SET - A combined tube set for a disposable water bottle for a medical instrument includes a cap with threads suitable for attachment to various water bottles. The combined tube set provides a first tube set for rinsing that includes an air and water tubes, and air/water connector The combined tube set also provides a second tube set for irrigation that includes an irrigation connector, backflow valve(s), and flexible tubing section. In some embodiments, the tube set can provide warm and/or humid gas to the endoscope.04-19-2012
20120095391CONNECTOR COMPRISING BACKFLOW VALVE FOR A TUBE SET - A connector is provided that is configured to pass a liquid from a bottle and a gas between a tube set assembly and a medical instrument, the tube set assembly comprising a first tube for gas flow and a second tube for liquid flow, the first and second tube contacting the connector, and a valve disposed within a flow path of the second tube and configured to prevent flow of the liquid back from the medical instrument to the bottle. The connector can be connected to a combined tube set for a disposable water bottle. The combined tube set provides a first tube set for rinsing that also includes air and water tubes.04-19-2012

Dina Gutkowicz-Krusin, Princeton, NJ US

Patent application numberDescriptionPublished
20080214907Quantitative Analysis Of Skin Characteristics - Skin characteristics are analyzed. A device acquires a digital image of an area of skin of a user. A processor quantitatively analyzes the digital image to determine a characteristic of all or part of the area of skin which is indicative of a skin condition of interest. Depending on the results of the quantitative analysis, the processor provides information to the user about the area of skin relative to the condition of interest. The information provided to the user is not necessarily sufficient for a definitive medical diagnosis and may include an indication to the user as to whether a knowledgeable person should evaluate the area of skin.09-04-2008
20080312952Regulating Use Of A Device To Perform A Procedure On A Subject - Among other things, whether a procedure can be performed on a subject using a procedure device, is governed based on control data prestored on a portable memory device; procedure data generated in connection with performing the procedure is stored on the portable memory device; the procedure data being stored in a manner that protects the privacy of the data in accordance with regulatory privacy restrictions that protect the subject with respect to the procedure.12-18-2008
20090060304DERMATOLOGY INFORMATION - Among other things, in connection with scanning a lesion on the skin of a subject, the location of the lesion on the subject is automatically determined. The scan and the location are stored on a portable memory device. And the memory device is included in a physical patient record of the subject for later use.03-05-2009
20110019888REDUCING NOISE IN DIGITAL IMAGES - A target digital image is received from an image sensor. The image is contaminated by noise of unknown magnitude that is represented by a reference digital image. A process is applied that uses statistical analysis of the target digital image and of the reference digital image to estimate a magnitude of the noise for at least some pixels of the target digital image.01-27-2011

Patent applications by Dina Gutkowicz-Krusin, Princeton, NJ US

Dina Katabi, Cambridge, MA US

Patent application numberDescriptionPublished
20110246881TRANSLATING TEXT TO, MERGING, AND OPTIMIZING GRAPHICAL USER INTERFACE TASKS - A system and method that enables a plurality of lay users to collaborate on automating computer tasks is disclosed. In one embodiment, the system automatically performs these tasks, rather than just documenting how to perform them. The system allows a database of solutions to be built for every important computer task. A key characteristic of this system is that users contribute to this database by simply performing the task. The system records the graphical user interface (GUI) actions as the user performs the task. It aggregates GUI traces from multiple users into a canonical sequence of GUI actions parameterized by user-environment that will successfully accomplish the task on a variety of different configurations. A classifier is used to predict which steps are likely to be misinterpreted and requests human intervention to properly perform them. This process can be done iteratively until the translation is believed to be correct.10-06-2011

Dina Lewinson, Zichron Ya'Akov IL

Patent application numberDescriptionPublished
20100003222METHODS FOR BONE REGENERATION USING ENDOTHELIAL PROGENITOR CELL PREPARATIONS - The present invention relates in general to orthopedics and to a method for promoting repair of large bone defects, in particular non-union or delayed union fractures. Specifically the invention concerns the use of endothelial progenitor cell preparations for bone repair.01-07-2010

Dina Piersawl, Northbrook, IL US

Patent application numberDescriptionPublished
20110243872CARBOHYDRATE TREATMENT FOR FRAGRANCED ARTICLES - A carbohydrate treatment composition composing modified starches, preservatives, an incorporation factor and water The treatment composition may also preferably comprise a fragrance The composition may be used to coat a litter material substrate and also may be used in a fragrance delivery composition for personal care products A method of coating a litter material using a carbohydrate material is also presented.10-06-2011

Dina Polosukhina, Franklin, TN US

Patent application numberDescriptionPublished
20110239953COLLECTION STATION FOR ACCELERATED COLLECTION OF THE SPECIMENS FROM LABORATORY ANIMALS - Embodiments of the invention include methods and apparatuses relating to animal specimen collection and animal specimen collection stations. In an embodiment, multiple chambers each contain a single animal, and wells on a removable floor on each of the chambers may collect animal specimens. The wells may be dimensioned with a depth and width such that the animals may not disturb, contact, or contaminate specimens contained within a well.10-06-2011

Dina Rahmi, Banten ID

Patent application numberDescriptionPublished
20110091395EXTRACT OF PHALERIA MACROCARPA AS AN ANTINEOPLASTIC, ANTI-INFLAMMATORY AND ANTIANGIOGENIC AGENT - A pharmaceutical dosage form comprising an extract of 04-21-2011

Dina Rosita, London CA

Patent application numberDescriptionPublished
20110110855NOVEL GHRELIN ANALOGUES - Ghrelin analogues having high affinity for a target receptor in diseased cells are provided, as well as methods of diagnosis and treatment utilizing such analogues.05-12-2011

Dina Scarpi, Firenze IT

Patent application numberDescriptionPublished
20100324294PROCESS FOR THE PREPARATION OF 2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLIN-3-CARBOXYLIC ACID ESTERS - The present invention relates to the process of preparation of 2,3,4,9-tetrahydro-1/−/-β-carbolin-3-carboxylic acid esters substituted in position 1 of the general formula (I). in the preferred diastereoisomeric form through a single step starting from tryptophan in racemic form and/or its enantiomers and from 3,4-(methylenedioxy)benzaldehyde.12-23-2010

Dina Sologub, Kirkland, WA US

Patent application numberDescriptionPublished
20080249097PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.10-09-2008
20090192099PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.07-30-2009
20090209505PRODRUGS OF HETEROARYL COMPOUNDS - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.08-20-2009
20110224434Prodrugs of Heteroaryl Compounds - The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.09-15-2011

Patent applications by Dina Sologub, Kirkland, WA US

Dina Thomas, Stanford, CA US

Patent application numberDescriptionPublished
20090031175SYSTEM AND METHOD FOR ANALYZING STREAMS AND COUNTING STREAM ITEMS ON MULTI-CORE PROCESSORS - Systems and methods for parallel stream item counting are disclosed. A data stream is partitioned into portions and the portions are assigned to a plurality of processing cores. A sequential kernel is executed at each processing core to compute a local count for items in an assigned portion of the data stream for that processing core. The counts are aggregated for all the processing cores to determine a final count for the items in the data stream. A frequency-aware counting method (FCM) for data streams includes dynamically capturing relative frequency phases of items from a data stream and placing the items in a sketch structure using a plurality of hash functions where a number of hash functions is based on the frequency phase of the item. A zero-frequency table is provided to reduce errors due to absent items.01-29-2009

Dina Tleugabulova, Hamilton CA

Patent application numberDescriptionPublished
20090104223Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations - The invention relates to a method for obtaining aggregated antigenic structures that are capable of enhancing an immune response to aggregate antigens administered systemically and/or mucosally generating powerful immune response and to the chemical structures resulting from the application of said method, to the formulations obtained from such structures and their use. The method describes the obtention of novel aggregate antigenic structures by using aggregating, delipidating or oxidating agents or compounds enabling the release of lipids from the particles and their heterogeneous aggregation, wherein aggregates with particle sizes of between 30 and 500 nm are subsequently selected by means of a molecular exclusion process. The aggregation state can also be provoket inside the yeast by changing incubation conditions. The resulting structures can be used conveniently adjuvated or in a formulation in which several antigens can be introduced, wherein synergism between said components is found with respect to the immunogenicity of the response obtained. The preparation may also contain stabilizers and preservatives. The resulting antigenic structures can be used in the pharmaceutical industry as preventive or therapeutic vaccine formulation both for human and veterinary use and as part of diagnostic system.04-23-2009

Dina Trifanova, Riga LV

Patent application numberDescriptionPublished
20110190342GLYCINE B ANTAGONIST - The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.08-04-2011

Dina Zhang, Watchung, NJ US

Patent application numberDescriptionPublished
20090264436CB-1 receptor modulator formulations - Described herein are solid, stable pharmaceutical formulations of cannabinoid receptor inverse agonists, such as taranabant, and processes of making such formulations. Additionally, described herein are solid stable pharmaceutical formulations of cannabiniod inverse agonists, such as taranabant, and an additional therapeutic agent, as well as processes for making such pharmaceutical formulations.10-22-2009
20090264476CB-1 receptor modulator formulations - Described herein are solid, stable pharmaceutical formulations of cannabinoid receptor inverse agonists, such as taranabant, and processes of making such formulations. Additionally, described herein are solid stable pharmaceutical formulations of cannabinoid inverse agonists, such as taranabant, and an additional therapeutic agent, as well as processes for making such pharmaceutical formulations.10-22-2009
20100009967SOLID DOSAGE FORMULATIONS OF TELCAGEPANT POTASSIUM - A solid dosage pharmaceutical formulation comprising as an active ingredient the potassium salt of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (telcagepant), arginine, and a pharmaceutically acceptable surfactant. The invention is also directed to an amorphous form of the potassium salt of telcagepant.01-14-2010
20100227903Polymer Formulations of CETP Inhibitors - A pharmaceutical composition comprises (a) a CETP inhibiting compound, or a pharmaceutically acceptable salt thereof; (b) a concentration-enhancing polymer, and (c) optionally one or more surfactants; wherein the compound has the structure shown as Formula I below. The composition raises HDL-cholesterol and lowers LDL-cholesterol.09-09-2010